Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience
-
Published:2021-06
Issue:3
Volume:60
Page:103077
-
ISSN:1473-0502
-
Container-title:Transfusion and Apheresis Science
-
language:en
-
Short-container-title:Transfusion and Apheresis Science
Author:
Malinowska IwonaORCID,
Romiszewski Michal,
Smalisz Katarzyna,
Stelmaszczyk - Emmel Anna,
Nasilowska - Adamska Barbara,
Krol Malgorzata,
Urbanowska Elzbieta,
Brozyna Agnieszka,
Baginska - Dembowska Bozenna
Reference25 articles.
1. Busulphan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial;Ladenstein;Lancet Oncol,2017
2. Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study;Lee;J Hematol Oncol,2017
3. The EBMT handbook;Carreras,2019
4. Indications for allo- and auto-SCT for haematological diseases, solid tumors and immune diseases: current practice in Europe, 2015;Sureda;Bone Marrow Transp,2015
5. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial;Gajjar;Lancet Oncol,2006
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献